Patient Empowerment Network

What can be done to overcome #bladdercancer disparities? Dr. Shaakir Hasan of @bethisraellahey discusses factors that contribute to disparities and proactive patient advice to help ensure optimal care and to self-advocate. ow.ly/YsE250YxF0e.

Registration is now open for the next #prostatecancer webinar! Sign up now to watch the webinar on 4/7 at 1pm ET which will focus on the latest treatment advances, the role of clinical trials, and tools to help patients self-advocate. Register now: powerfulpatients.org/event/evolving…

Nearly 1 in 3 cancer patients face barriers beyond diagnosis - transportation, finances, location - impacting care decisions. #APOS2026 #PsychosocialOncology #PatientEmpowerment #CancerCare #SDOH #HealthEquity #CancerResearch

How can #lungcancer patients overcome barriers to treatment? Dr. Narjust Florez from @DanaFarber discusses the impacts of barriers in communication, transportation, and childcare and why communication matters for patients to receive the best care. ow.ly/1Qeu50YwRG7 #lcsm

"You are the CEO of your own care." 💪 Learn about PEN's [ACT]IVATED program empowering patients across 17 diseases. powerfulpatients.org #APOS2026 #PsychosocialOncology #PatientEmpowerment #HealthEquity #SDOH #SharedDecisionMaking #CancerCare

"You are the CEO of your own care." Aïcha Diallo shared PEN's patient-centered [ACT]IVATED program at #APOS2026. Learn more: powerfulpatients.org #PsychosocialOncology #PatientEmpowerment #HealthEquity #SDOH #SharedDecisionMaking #CancerCare

Dr. Joshua Cohen of @cityofhopeoc highlights the latest #cervicalcancer research, including the role of immunotherapy, newly approved targeted therapies for recurrent cervical cancer, and emerging treatment approaches showing promise for patients. ow.ly/9PZB50YwoL9 #gyncsm

Attend Today’s CAR T-Cell Therapy Webinar "Stronger Together: Essential Advice for CAR T-Cell Therapy Care Partners"- mailchi.mp/powerfulpatien…

Dr. Joshua Cohen of @cityofhopeoc explores the evolving science behind biomarker testing, explains why comprehensive testing matters, and highlights how clinical trials are driving innovation in diagnosis and treatment for #endometrialcancer. ow.ly/YyFe50YvT5M #gyncsm

Myeloma patient, Lisa Hatfield, speaks with Dr. Krina K. Patel of @UTMDAnderson about the innovations shaping the durability of CAR T-Cell Therapy responses in myeloma. ow.ly/IvEl50YvSCG #mmsm

What can #lungcancer patients do if they feel dismissed? Dr. Narjust Florez of @DanaFarber shares strategies for communicating symptoms, navigating bias, engaging in productive dialogue with doctors, and advocating for your care. ow.ly/h2EY50YvlVs #lcsm

Dr. Krina Patel of @UTMDAnderson discusses encouraging new clinical trial data for people with #multiplemyeloma after their first relapse. She explains what makes the results so promising and why supportive care is essential to safely manage treatment. ow.ly/UvWk50YuMQW

Dr. Demetria Smith-Graziani of @WinshipAtEmory and Dr. Folasade May of @UCLAKP_CHE explain how healthcare providers can quantify disparities using established public health frameworks. They discuss practical ways to track upstream drivers of inequity. ow.ly/JYFl50Ytslg.

Join us next week for the webinar "Stronger Together: Essential Advice for CAR T-Cell Therapy Care Partners" with Dr. Krina Patel from @MDAndersonNews on March 19th at 1pm ET | 10am PT. Register here: ow.ly/gpb250YiWtZ #mmsm

Dr. Narjust Florez of @DanaFarberNews explains #lungcancer testing, questions to ask, how test results guide treatment, what to expect from treatment side effects, and why language access is critical for fully understanding your diagnosis and options. ow.ly/Ci2B50YsSF0

After months of unexplained infections and exhaustion, Jeanine was diagnosed with acute myeloid leukemia (#AML). She shares how trusting her body, asking questions, and building support helped her regain control and why speaking up matters. ow.ly/AX3v50YsmrP #leusm

Hidden blind spots are shaping cancer outcomes. Dr. Woods-Burnham of @MoffittNews explains how misclassified cell lines and overlooked risks in primary care lead to missed opportunities for early detection and equitable, personalized #prostatecancer care. ow.ly/UX6750Ysmeu

Why does inclusion in prostate cancer clinical trials matter? Dr. Leanne Woods-Burnham of @MSMEDU explains why diverse participation is essential for developing effective treatments. ow.ly/MKXi50YrSkM #pcsm

Considering a #myelofibrosis clinical trial? Dr. Gabriela Hobbs of @MassGeneralNews shares advice to learn about clinical trials—from understanding the time commitment to finding reputable resources and nearby options. ow.ly/Suoo50YrRYP #mpnsm

How can you receive an accurate #endometrialcancer diagnosis? Dr. Joshua Cohen from @cityofhopeoc explains the diagnostic process step-by-step, including key tests, as well as the role of imaging and staging. powerfulpatients.org/resource/essen… #gyncsm